Early initiation of irbesartan provides maximum cost benefits

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.460, 2004-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The routine use of the Angio-Seal STS device provides clinical and cost benefits compared with conventional femoral haemostasis methods

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 515, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer: What is the Optimal Initiation Time for the Maximum Benefit?

By Needleman Sarah J. Tobias Jeffrey S.

Drugs, Vol. 68, Iss. 1, 2008-01 ,pp. : 1-15

Adis International

Access to resources Recommend Favorite

Ezetimibe/simvastatin provides VYTAL benefits in diabetic patients

Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Rosuvastatin provides superior benefits in lipid therapy

Inpharma, Vol. 1, Iss. 1282, 2001-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

FOLFIRINOX provides QOL benefits in pancreatic cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 669, 2013-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite